RSV Infection Clinical Trials

9 recruitingLast updated: June 18, 2026

There are 9 actively recruiting rsv infection clinical trials across 9 countries. Studies span Phase 3, Not Applicable, Phase 1, Phase 2. Top locations include Santiago de Compostela, A Coruña, Spain, Johannesburg, Gauteng, South Africa, Aurora, Colorado, United States. Updated daily from ClinicalTrials.gov.


RSV Infection Trials at a Glance

9 actively recruiting trials for rsv infection are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Phase 3 with 2 trials, with the heaviest enrollment activity in Santiago de Compostela, Johannesburg, and Aurora. Lead sponsors running rsv infection studies include Association Clinique Thérapeutique Infantile du val de Marne, Clover Biopharmaceuticals USA, LLC, and Assistance Publique - Hôpitaux de Paris.

Browse rsv infection trials by phase

Treatments under study

About RSV Infection Clinical Trials

Looking for clinical trials for RSV Infection? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new RSV Infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about RSV Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 3

A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose

RSV Infection
Pfizer550 enrolled97 locationsNCT06866405
Recruiting
Phase 3

A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo.

preterm labourRSV ImmunisationRSV Infections
University of Witwatersrand, South Africa13,000 enrolled11 locationsNCT06955728
Recruiting
Not Applicable

RSV Burden in Outpatient and Hospital Settings

RSV InfectionChildren, OnlyOtitis+1 more
Association Clinique Thérapeutique Infantile du val de Marne1,900 enrolled1 locationNCT04743609
Recruiting

Real-World Effectiveness of Perinatal RSV Immunoprophylaxis

RSV Infection
Yale University3,750 enrolled1 locationNCT06172660
Recruiting

Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France

RSV Infection
Assistance Publique - Hôpitaux de Paris400 enrolled1 locationNCT06881953
Recruiting
Phase 1

Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults

RSV Infection
Clover Biopharmaceuticals USA, LLC160 enrolled5 locationsNCT06843317
Recruiting
Phase 2

RSV Vaccination in Immunocompromised Patients.

RSV Infection
Medical University of Vienna200 enrolled1 locationNCT06597916
Recruiting

Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control

AsthmaRSV InfectionPertussis
Hospital Clinico Universitario de Santiago784 enrolled1 locationNCT06286007
Recruiting

Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization

RSV Infection
Federico Martinón Torres42,000 enrolled1 locationNCT06180993